Ultragenyx Pharmaceutical (RARE) has earned its first FDA approval in gene therapy, landing an accelerated green light for its treatment targeting glycogen storage disease type Ia. The FDA approved pariglasgene brecaparvovec-opnr, previously
IBM (NYSE: IBM) shares dropped sharply by 25% after the company issued a warning related to its second quarter outlook on AI spending. The significant share price decline reflects growing investor concern
More
Outgoing Prime Minister Sir Keir Starmer collected sport-related freebies worth tens of thousands of pounds during his two years in Downing Street. Official figures declared in the register of accepted gifts and
More
Germany’s sweeping health insurance overhaul is colliding with a US Section 301 trade investigation, creating mounting pressure across global pharmaceutical supply chains. A fixed 15.5% manufacturer rebate on patented branded drugs has
More
A series of recent US Supreme Court decisions has fundamentally shifted how regulatory challenges must be approached, placing threshold questions ahead of traditional administrative review. Businesses have long focused on whether agency
More
London’s FTSE 100 closed higher on Friday, bucking a broader global trend as utility stocks provided support amid a turbulent session driven by semiconductor weakness. The FTSE 100 Index finished up 28.13
More
KPMG and Deloitte are offering UK staff significantly enhanced redundancy packages as both firms move to reduce headcount and trim operational costs. The two accountancy giants, alongside PwC, have ramped up payouts
More
Delaware has moved decisively to modernise its financial regulatory framework after Governor Matt Meyer signed three landmark bills into law on July 6, 2026. The legislation covers state-chartered banks, money transmitters, virtual
More
Nokia (NYSE: NOK) has attracted fresh attention from analysts suggesting the Finnish telecoms giant may currently be trading below its fair value. The stock has been under scrutiny as investors weigh near-term
More
Rotork and Trustpilot experienced sharply contrasting fortunes during a notable FTSE 250 trading session that captured the attention of London market watchers. Rotork, the flow control and instrumentation specialist listed on the
More
Foundation Medicine has announced a new initiative designed to raise awareness about the critical role of quality and accuracy in cancer biomarker testing. The Quality First initiative centres on patient advocate stories
More